Back to discover
Disease

Speech Disorders

Clinical development underwayEmerging research
1
Publications
3
Clinical trials
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

2 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential
Recent publications
Major themes1
  • Brain-Computer Interfaces1
Leading journals1
  • Journal of neurology1
Leading researchers8
  • Aicardi C1
  • Akram H1
  • Carolan J1
  • Layard Horsfall H1
  • Marcus HJ1
  • Muirhead WR1
  • Schaefer AT1
  • Vanhoestenberghe A1
Affiliations (unnormalised)6
  • King's College London1
  • School of Biomedical Engineering and Imaging Sciences1
  • The Francis Crick Institute1
  • The National Hospital for Neurology and Neurosurgery1
  • UCL Queen Square Institute of Neurology1
  • Wolfson Institute for Biomedical Research1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.